IP Library Granted Patent US 11,058,742
Granted Patent B2
US 11,058,742 · App. 16/797,211 · Granted Jul 13, 2021

Food composition for suppressing hepatic lipogenesis

Inventors: Hiroshi Inoue (Kanazawa, JP); Kumi Kimura (Ishikawa, JP); Nobuhiko Tachibana (Moriya, JP)
Assignee: FUJI OIL HOLDINGS INC.
A61K38/05A23L33/18A61K38/16A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,058,742
App. No.
16/797,211
Granted
Jul 13, 2021
Kind
B2
Abstract

A peptide having an effect of suppressing hepatic lipogenesis, where a peptide is one or two or more peptides selected from 11 dipeptides (Ala-Gly, His-Asn, His-Ser, His-Thr, His-Trp, Val-Met, Trp-Glu, Trp-Lys, Tyr-Lys, Tyr-Ser and Tyr-Tyr) and 25 tripeptides (Val-Ile-Leu, Gly-Ser-Leu, Val-Leu-Gln, His-Ala-Gln, Arg-Ala-Val, Lys-Leu-Gly, Ile-Val-Ile, Lys-Pro-Ile, Leu- Val-Ile, Leu-Arg-Asp, Gln-Glu-Glu, Ser-Gly-Glu, Arg-Trp-Phe, Asp-Phe-Phe, Asp-Val-Phe, Pro-Phe-Tyr, Phe-Ile-Arg, Asn-Gly-Arg, Ile-Ile-Pro, Ile-Asp-Arg, Ile-His-Arg, Ile-Asp-Arg, Asn-Arg-Val, Ser-Ser-Val and Val-Phe-Val), is provided. The peptide may be used in a food composition for suppressing hepatic lipogenesis and an agent for suppressing hepatic lipogenesis.

Claims (4)

1. A method for suppressing hepatic lipogenesis in a subject in need thereof, comprising administering to the subject an agent for suppressing hepatic lipogenesis comprising one or more peptide selected from the group consisting of His-Asn, His-Ser, His-Thr, His-Trp, Trp-Glu, Trp-Lys, Tyr-Lys, Tyr-Ser, and Tyr-Tyr, as an active ingredient.

2. The method according to claim 1 , wherein the peptide as an active ingredient is one or more dipeptide selected from the group consisting of His-Asn, His-Ser, His-Thr, His-Trp, Tyr-Lys, Tyr-Ser and Tyr-Tyr.

3. The method according to claim 1 , wherein the peptide as an active ingredient is one or more dipeptide selected from the group consisting of His-Asn, His-Ser, His-Thr, His-Trp, Trp-Glu, and Trp-Lys.

4. The method according to claim 1 , wherein the peptide as an active ingredient is one or more dipeptide selected from the group consisting of His-Asn, His-Ser, His-Thr, and His-Trp.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2020
From: INOUE, HIROSHI; KIMURA, KUMI; TACHIBANA, NOBUHIKO
To: FUJI OIL HOLDINGS INC.
Reel/Frame 051886/0634 →
Priority Claims (2)
JP JP2019-031375 · Feb 25, 2019 · national
JP JP2019-031376 · Feb 25, 2019 · national
Continuity (1)
Related Publication 20200268828A1 · Aug 27, 2020